Robert John Dempsey
Known title: CHIEF EXECUTIVE OFFICERCIK: 0002125298
Associated companies
Transaction History
| OKYO | ▲ Buy | Grant | 15,000 | $23K | 7/22/2026 | View on chart |
| OKYO | ▲ Buy | Grant | 15,000 | $23K | 7/22/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
OKYO Pharma to Present at Ophthalmic Scientific Conferences
OKYO Pharma announced it will present and participate in several upcoming ophthalmic scientific conferences. The company’s involvement highlights its focus on eye‑care products and may increase visibility among researchers and clinicians. This activity could support interest in OKYO’s pipeline as the firm seeks to advance its ophthalmic therapies.
OKYO Pharma to Present at Ophthalmic Scientific Conferences. OKYO Pharma announced it will present and participate in several upcoming ophthalmic scientific conferences. The company’s involvement highlights its focus on eye‑care products and may increase visibility among researchers and clinicians. This activity could support interest in OKYO’s pipeline as the firm seeks to advance its ophthalmic therapies.